Continental Advisors’s Elevance Health ELV Stock Holding History

Continental Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-500	Closed	-$57.4K	–	154
2014 Q2	$54K	Buy	+500	New	+$51.5K	0.01%	132
2013 Q4	–	Sell	-10,000	Closed	-$836K	–	144
2013 Q3	$836K	Sell	10,000 -10,000	-50%	-$857K	0.21%	104
2013 Q2	$1.64M	Buy	+20,000	New	+$1.5M	0.46%	66

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Continental Advisors's ELV Position: Q3 2014 in Review

Continental Advisors sold out of Elevance Health (ELV) in Q3 2014, closing a stake of 500 shares — an estimated $57.4K sold.

Continental Advisors first reported a position in ELV in Q2 2013 and held it in 3 quarters. The position peaked at $1.64M in Q2 2013. 708 funds tracked by Wall St. Rank hold ELV as of Q3 2014.

Continental Advisors reported no remaining Elevance Health position as of Q3 2014 after selling out during the quarter.
Continental Advisors sold 500 Elevance Health shares in Q3 2014, an estimated $57.4K.
Continental Advisors first reported a position in Elevance Health in Q2 2013 and held it in 3 quarters.
Continental Advisors's Elevance Health position peaked at $1.64M in Q2 2013.
708 funds tracked by Wall St. Rank held Elevance Health as of Q3 2014.

Based on Continental Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.